Avanos Medical AVNS
NYSE AVNS
$24.99 +0.01 (+0.04%)
At close: Jul 24, 2026 · 4:03 PM EDT

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018)

Avanos Medical's (AVNS) quarterly Other Accumulated Expenses came in at $34.1 million in Q3 2018, up 16.78% quarter-over-quarter from $29.2 million in Q4 2017.

Analysis

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018) Analysis & Trends

Avanos Medical has disclosed Other Accumulated Expenses across 2 years of filings, most recently posting $34.1 million for Q3 2018.

  • In Q3 2018, Other Accumulated Expenses changed N/A year-over-year to $34.1 million; the TTM figure through Sep 2018 stood at $34.1 million (changed N/A YoY), while the FY2017 annual figure was $29.2 million, changed N/A from the prior year.
  • Other Accumulated Expenses came in at $34.1 million for Q3 2018 at Avanos Medical, up from $29.2 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $34.1 million in Q3 2018 to a low of $29.2 million in Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 34.10 Mn
Dec 31, 2017 29.20 Mn